 

(For Collection of Cancerous Tissue)

 

 

[Informed Consenli

 

purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient an answered any questions the patient had. The patient then signed the
consent form as a tree and voluntary act. A copy of thi '
our institution.

Name of Physician or Study Coordinator

I personally informed this “that a specimen(s) would be collected to be used for research

      

Signature Date

 

[Clinical Information]

 

Marital Status

Heart Rate

ChiefComplaints: No 01D m Var/(m 3 (\SLOX

Symptoms: \ .
/ \lo 9) Wk lo (7 3

Clinical Findings:

Performance Scale (Karnofsky Score):

1:1 100 Asymptomatic El 80-90 Symptomatic but Fully Ambulatory :1 60-70 Symptomatic, in bed less than 50% of day
40-50 S in bed more than 50% of but not bed ridden [:1 20-30 Bed Ridden

 

 

 

 

 

_ . . PAST MEDICAL HISTORY. E
Diagnosis] Disease] Disorder] Injury Diagnosis Date

 

Treatment Status

 

 

 

 

 

 

 

 

 

 

Environmental Hazards:
Smoki H
Current Status 3 Packs
CI YES 0 '

Duration

Alcohol Consum
Current Status . TYPE Drinks Duration
El YES 0

Use
Current Status

El YES 0

Duration

Relative

Test Result Result

HIV El Positive: ' El Positive:
H B El Positive: El N D Positive:
H C ‘ [1 Positive: El ' Ci Positive:

AFP D D Positive: D [3 Positive:
Other:

D Negative El Positive: El Negative El Positive:

B/T Cell Markers:

 

 

 
 
  
 

  

Ultrasound
X-Ra
CT

Location of

T N M

 

 

 

Results

 
   

Clinical

Involved L Nodes Location of Distant Metastasis

‘4

Clinical

Stage: f2 [2

 

Treatment Informationl -

 

Procedure

ma Tumor
Detailed Location

\ 65
Extension of Tu

L Nodes

Location of L Nodes

Palpable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes

reatment

 

Distant Metastasis

Detailed Location

ical S
N M

Su

 

 

 

Pathology Form

 

[Specimen Information!

Collected by: Date: im
Preserved by: Date im
Frozen Parafﬁn Block Blood/Serum/Plasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal

2

    

Time to LN2 to Formalin Time to LN2

Prima Tumor
Size Extension of Tumor Distance to T
x ' cm ’ ' cm
Nodes
Location # Exa # Metastasized

Distant Metastasis
Detailed Location

Patho icalS in
pT N 4/ M 0 Stage: 12?

2., o/a/Qc (W18) cam We; a; ﬂ/wﬂgeéa

 

 

    

OSTIC PATHOLOGY FORM*

Microscopic Appearance:

1. Histological pattern:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

D'ff CELL DISTRIBUTION + - STRUCTURAL PATTERN + -
Ml use X Streaming
“a”, 0/ Storiform
Necrosns Y Fibrosis
L mphocytic Infiltration 5? Palisading
Vascular Invasion q Cystic Degeneration
Clusterized Bleedini
Alveolar Formation ix Myxoid Change
Indian File ? PsammomalCalciflcation
2. Cellular ﬁamres:
Squamous + - Adenomatous + - Sarcomatous + - Lymphomatous + -
Squamoid Cell Glandular cell ‘( Round Cell LarsLCell
s indle Cell Cell Stratiﬁcation ll Fibroblast Small Cell
Keralin Secretion U Osteoblast RS Cell/RS Like
Desmosome lniracyt Vacuole ix Lipoblast lnilam. Cell
Pearl Gland formation 4 Myoblast Plasma Cell
. . _ ,
omenvtse Speciﬁed. D1 If 07' UL 9177/ (72 W7, pa ((7, _ W W
2. Cellular Di eremiation: J
Well Mwﬁwd’ Poor

 

 

 

 

 

 

3. Nuclear

Mitotic ‘ Nuclear Grade

 

Pam/mu) xiv/Wag; ﬁts/W 6"?

7 WPM/ne/l‘v 4”

Histological Diagnosis:

Comments: M/ "

           

  

E ONLY)
Fog RESEARCH us
mowersr STAFF

Wm M»-

RT or FINDINGS BY

*(INIEGRATED REPO

